CLINICAL TRIALS PROFILE FOR ORABASE HCA
✉ Email this page to a colleague
All Clinical Trials for ORABASE HCA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02329600 ↗ | Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus | Completed | Cairo University | Phase 3 | 2013-06-01 | The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets. |
NCT02645656 ↗ | Topical Application of Curcumin Orabase in Oral Submucous Fibrosis (OSMF) | Unknown status | SVS Institute of Dental Sciences | Phase 2 | 2013-12-01 | Curcumin (diferuloylmethane) is the chief component of the spice turmeric and is derived from the rhizome of the East Indian plant Curcuma longa. Curcuma longais a member of the Zingiberacae (ginger) family of botanicals and is a perennial plant that is native to Southeast Asia. Turmeric contains a class of compounds known as the curcuminoids, comprised of curcumin, demethoxy curcumin and bisdemethoxycurcumin. |
NCT03026478 ↗ | Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus | Unknown status | Garlapati Komali | Phase 2 | 2016-05-06 | Oral Lichen Planus (OLP) is an autoimmune, chronic inflammatory mucocutaneous disease characterized by pain and burning sensation. The major types of OLP are the following: reticular, atrophic, erosive-ulcerative, bullous and pigmentous form.Its etiology remains unclear. The presence of auto-cytotoxic T cell clones in the lesions suggests the role of autoimmunity. Numerous treatment options of OLP include topical and systemic agents depending on severity of lesions . Topical corticosteroids abide the mainstay of therapy,and are widely accepted as the primary treatment of choice.Hence this study is designed to evaluate and compare the clinical efficacy of topical Clobetasol 0.05% in orabase and Betamethasone 0.05% in orabase in combination with Clotrimazole 1% in the management of symptomatic Oral Lichen Planus. |
NCT03415165 ↗ | Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus | Unknown status | Cairo University | Early Phase 1 | 2018-01-03 | Is topical application of green tea polyphenols buccal tablet more effective in treatment of patients with symptomatic oral lichen planus in comparison with topical application of corticosteroids and what is the most effective concentration of polyphenols |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ORABASE HCA
Condition Name
Clinical Trial Locations for ORABASE HCA
Clinical Trial Progress for ORABASE HCA
Clinical Trial Phase
Clinical Trial Sponsors for ORABASE HCA
Sponsor Name